Biotechnology

Filter

Current filters:

None

Popular Filters

1900 to 1924 of 2523 results

EMA 2013 work program and budget endorsed by management board

18-12-2012

The European Medicines Agency's Management Board revealed yesterday that, at its meeting on December…

BiotechnologyEuropeFinancialGenericsPharmaceuticalRegulation

Actelion's ponesimod does well in mid-stage psoriasis trial

18-12-2012

Europe's largest biotech firm Actelion (SIX: ATLN) says that its selective S1P1 modulator, ponesimod,…

ActelionBiotechnologyImmunologicalsponesimodResearch

Vivalis and Intercell announce "merger of equals"

18-12-2012

French biotech firm Vivalis (Euronext: VLS) has entered into an accord to acquire Intercell (ICEL.VI)…

BiotechnologyIntercellMergers & AcquisitionsVaccinesValnevaVivalis

UK's NICE says Roche's Avastin not cost effective for advanced ovarian cancer

18-12-2012

The UK drugs watchdog the National Institute for Health and Clinical Excellence (NICE) has published…

AvastinBiotechnologyEuropeOncologyPharmaceuticalPricingRegulationRoche

Enzon mulls sale of company; Bio-Rad to acquire business from MorphoSys

18-12-2012

USA-based Enzon Pharmaceuticals (Nasdaq: ENZN) said yesterday that its board has retained Lazard to act…

Bio-Rad LaboratoriesBiotechnologyEnzon PharmaceuticalsMergers & AcquisitionsMorphoSys

Fresenius Kabi sells respiratory homecare business in France

17-12-2012

Germany-based Fresenius Kabi, a provider of infusion therapy and clinical nutrition. has signed an agreement…

BiotechnologyFresenius BiotechFresenius KabiMergers & AcquisitionsPharmaceuticalRespiratory and Pulmonary

AstraZeneca presents mixed data on fostamatinib in RA

13-12-2012

Shares of Anglo-Swedish drug major AstraZeneca (LSE: AZN) fell 2.1% to $47.88 in premarket US trading…

Anti-Arthritics/RheumaticsAstraZenecaBiotechnologyfostamatinibPharmaceuticalResearchRigel Pharmaceuticals

Gilead agrees to buy YM BioSciences for $510 million

13-12-2012

US biotech firm Gilead Sciences (Nasdaq: GILD) has agreed to acquire Canada's YM BioSciences (TSX: YM)…

BiotechnologyCYT387Gilead SciencesMergers & AcquisitionsOncologyPharmaceuticalYM Biosciences

European Parliament approves unitary patent rules

12-12-2012

Following the historic vote yesterday in the European Union Parliament to approve the unitary patent…

BiotechnologyEuropeLegalPatentsPharmaceutical

Amgen paying $415 to acquire deCODE Genetics

11-12-2012

In what has been a busy M&A period for US biotech giant Amgen (Nasdaq: AMGN), the company has entered…

AmgenBiotechnologydeCODE GeneticsMergers & AcquisitionsPharmaceutical

Biogen Idec and Isis Pharma in up to $230 million antisense deal

11-12-2012

USA-based companies Biogen Idec (Nasdaq: BIIB) and Isis Pharmaceuticals (Nasdaq: ISIS) have entered into…

Biogen IdecBiotechnologyIsis PharmaceuticalsLicensingNeurologicalResearch

Japan Tobacco files for Japanese approval of elvitegravir

11-12-2012

Japan Tobacco (TSE:2914) has filed a New Drug Application for marketing approval of a novel anti-HIV…

Anti-viralsAsia-PacificBiotechnologyelvitegravirGilead SciencesJapan TobaccoPharmaceuticalRegulationTorii Pharma

1900 to 1924 of 2523 results

Back to top